For his Wilhelm Conrad Röntgen Honorary Lecture at ECR 2011, Professor Richard Baron MD, from the Radiology Department at the University of Chicago, USA, focused on Detecting liver tumours: the search for the Holy Grail. Why does he compare this aim with that of the medieval knights?
EH Paris correspondent Annick Chapoy, reports on a French study that confirms the relevance of a drug with a long history in the management of other diseases
Devised by the European Liver Test group, the new, non-invasive Enhanced Liver Fibrosis (ELF) test on Siemens ADVIA Centaur Immunoassay Systems can identify, in under an hour, bloodbased biomarkers to detect the amount of fibrosis in the liver.
A Birmingham hospital is pioneering a new procedure which aims to maintain and improve the quality of organs for transplantation in recipients on the waiting list.
People who donate a portion of their livers for transplant to a relative or friend whose liver is failing can generally expect to live long, healthy lives and recover safely from the donation surgery, Johns Hopkins researchers have found.
Susanne Werner reports on the views and revelations of international researchers gathered to deliberate the future potential of reprogrammed human adult stem cells and personalised medical treatments
The European Research Council (ERC) has earmarked about €2.5 mio. to fund the research being conducted by gastroenterologist and biochemist Professor Dr. Dr. Detlef Schuppan at Mainz University Medical Center. Professor Schuppan is a specialist in liver diseases ranging from fibrosis to cirrhosis (the terminal stage of fibrosis) to hepatic cancer.
A Birmingham hospital trust is expanding its kidney dialysis service by commissioning a tenth satellite unit – its first outside England. University Hospitals Birmingham NHS Foundation Trust is to provide a chronic haemodialysis facility at a hospital in Powys, mid-Wales.